AMPH: Amphastar Pharmaceuticals, Inc. Stock

by  •  • Comments Off on AMPH: Amphastar Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,605.92
Enterprise Value ($M) 2,010.50
Book Value ($M) 727.68
Book Value / Share 15.13
Price / Book 2.21
NCAV ($M) -271.55
NCAV / Share -5.65
Price / NCAV -5.91

Profitability (mra)
Return on Invested Capital (ROIC) 0.12
Return on Assets (ROA) 0.10
Return on Equity (ROE) 0.25

Liquidity (mrq)
Quick Ratio 2.61
Current Ratio 3.43

Balance Sheet (mrq) ($M)
Current Assets 545.95
Assets 1,545.18
Liabilities 817.50
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-06 13G/A Federated Hermes, Inc. 4.52 -33.85
02-13 13G/A Vanguard Group Inc 5.88 7.36
02-09 13G/A Zhang Jack Y. 26.20 2.48
2024-01-23 13G/A BlackRock, Inc. 12.60 -14.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 90,831 365,595 24.84
2025-02-03 126,466 507,981 24.90
2025-01-31 106,180 442,147 24.01
2025-01-30 101,851 372,573 27.34

(click for more detail)

Similar Companies
ALXO – ALX Oncology Holdings Inc. AMGN – Amgen Inc.
AMLX – Amylyx Pharmaceuticals, Inc. AMRX – Amneal Pharmaceuticals, Inc.
ANAB – AnaptysBio, Inc.


Financial data and stock pages provided by
Fintel.io